tetano
Editor, Senior Moderator
Viruses
. 2021 Dec 23;14(1):17.
doi: 10.3390/v14010017.
Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus
Adrianna Klajmon[SUP] 1 [/SUP], Aldona Olechowska-Jarząb[SUP] 2 [/SUP], Dominika Salamon[SUP] 3 [/SUP], Agnieszka Sroka-Oleksiak[SUP] 3 [/SUP], Monika Brzychczy-Włoch[SUP] 3 [/SUP], Tomasz Gosiewski[SUP] 3 [/SUP]
Affiliations
Abstract
Diagnostics of the coronavirus disease 2019 (COVID-19) using molecular techniques from the collected respiratory swab specimens requires well-equipped laboratory and qualified personnel, also it needs several hours of waiting for results and is expensive. Antigen tests appear to be faster and cheaper but their sensitivity and specificity are debatable. The aim of this study was to compare a selected antigen test with quantitative polymerase chain reaction (qPCR) tests results. Nasopharyngeal swabs were collected from 192 patients with COVID-19 symptoms. All samples were tested using Vitassay qPCR SARS-CoV-2 kit and the Humasis COVID-19 Ag Test (MedSun) antigen immunochromatographic test simultaneously. Ultimately, 189 samples were tested; 3 samples were excluded due to errors in taking swabs. The qPCR and antigen test results were as follows: 47 positive and 142 negative, and 45 positive and 144 negative, respectively. Calculated sensitivity of 91.5% and specificity of 98.6% for the antigen test shows differences which are not statistically significant in comparison to qPCR. Our study showed that effectiveness of the antigen tests in rapid laboratory diagnostics is high enough to be an alternative and support for nucleic acid amplification tests (NAAT) in the virus replication phase in the course of COVID-19.
Keywords: COVID-19; NAAT; SARS-CoV-2; antigen test; laboratory diagnostics; qPCR.
. 2021 Dec 23;14(1):17.
doi: 10.3390/v14010017.
Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus
Adrianna Klajmon[SUP] 1 [/SUP], Aldona Olechowska-Jarząb[SUP] 2 [/SUP], Dominika Salamon[SUP] 3 [/SUP], Agnieszka Sroka-Oleksiak[SUP] 3 [/SUP], Monika Brzychczy-Włoch[SUP] 3 [/SUP], Tomasz Gosiewski[SUP] 3 [/SUP]
Affiliations
- PMID: 35062221
- DOI: 10.3390/v14010017
Abstract
Diagnostics of the coronavirus disease 2019 (COVID-19) using molecular techniques from the collected respiratory swab specimens requires well-equipped laboratory and qualified personnel, also it needs several hours of waiting for results and is expensive. Antigen tests appear to be faster and cheaper but their sensitivity and specificity are debatable. The aim of this study was to compare a selected antigen test with quantitative polymerase chain reaction (qPCR) tests results. Nasopharyngeal swabs were collected from 192 patients with COVID-19 symptoms. All samples were tested using Vitassay qPCR SARS-CoV-2 kit and the Humasis COVID-19 Ag Test (MedSun) antigen immunochromatographic test simultaneously. Ultimately, 189 samples were tested; 3 samples were excluded due to errors in taking swabs. The qPCR and antigen test results were as follows: 47 positive and 142 negative, and 45 positive and 144 negative, respectively. Calculated sensitivity of 91.5% and specificity of 98.6% for the antigen test shows differences which are not statistically significant in comparison to qPCR. Our study showed that effectiveness of the antigen tests in rapid laboratory diagnostics is high enough to be an alternative and support for nucleic acid amplification tests (NAAT) in the virus replication phase in the course of COVID-19.
Keywords: COVID-19; NAAT; SARS-CoV-2; antigen test; laboratory diagnostics; qPCR.